Epigenetic Cancer Therapy unites issues central to a translational audience actively seeking to understand the topic. It is ideal for cancer specialists, including oncologists and clinicians, but also provides valuable information for researchers, academics, students, governments, and decision-makers in the healthcare sector.
The text covers the basic background of the epigenome, aberrant epigenetics, and its potential as a target for cancer therapy, and includes individual chapters on the state of epigenome knowledge in specific cancers (including lung, breast, prostate, liver).
The book encompasses both large-scale intergovernmental initiatives as well as recent findings across cancer stem cells, rational drug design, clinical trials, and chemopreventative strategies. As a whole, the work articulates and raises the profile of epigenetics as a therapeutic option in the future management of cancer.
"synopsis" may belong to another edition of this title.
An ideal companion for translational researchers and clinicians conducting R&D, and for those considering incorporating epigenetic targeting agents into clinical trial protocols
"About this title" may belong to another edition of this title.
Shipping:
£ 14.99
From United Kingdom to U.S.A.
Book Description Hardcover. Condition: New. Seller Inventory # 6666-ELS-9780128002063
Book Description Condition: new. Questo è un articolo print on demand. Seller Inventory # 2107fb4cfa271f5a438502e46456977a
Book Description Hardcover. Condition: Brand New. 1st edition. 748 pages. 9.40x7.70x1.70 inches. In Stock. Seller Inventory # __0128002069